Literature DB >> 26052565

Effectiveness of bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: an echocardiographic study of left ventricular remodeling.

Fujian Duan1, Zhi Qi1, Sheng Liu2, Xiuzhang Lu1, Hao Wang3, Yiming Gao1, Jianpeng Wang1.   

Abstract

AIMS: The graft of stem cells to treat ischemic cardiomyopathy is popular in many clinical trials. The aim of this study was to evaluate the effectiveness of isolated coronary artery bypass graft combined with bone marrow mononuclear cells (BMMNC) delivered through graft vessels to improve left ventricular remodeling of patients with previous myocardial infarction and chronic heart failure using echocardiography.
MATERIAL AND METHODS: Patients with previous myocardial infarction and chronic heart failure were randomly allocated to one of the two groups: CABG only (18 patients), or CABG with BMMNC transplantation (24 patients). Echocardiographic parameters were measured on B-mode imaging, 3D imaging and color flow imaging. RESULTS Post-operative LVEDD (end-diastolic dimension of left ventricle), LVESD (end-systolic dimension of left ventricle), LVEDV (end-diastolic volume of left ventricle), LVESV (end-systolic volume of left ventricle), LVEDVI (LVEDV indexed to body surface area), LVESVI (LVESV indexed to body surface area), LV-mass (mass of left ventricle) and LV-massI (LV-mass indexed to body surface area) were significantly improved compared with those obtained prior to operation in CABG+BMMNC group (al p<0.05). The same parameters were not significantly different pre- and postoperative in the CABG group (al p>0.05). Postoperative mitral regurgitation score was not significantly different from those prior to operation in both groups (al p>0.05). In Chi-square tests, LVEDD, LVESD, LVEDV, LVESV, LVEDVI, LVESVI, LV-mass, LV-massI were determinants of the left ventricular remodeling.
CONCLUSION: The improvement of left ventricular remodeling in CABG+BMMNC group was better than in the CABG group and this improvement was verified by echocardiography.

Entities:  

Mesh:

Year:  2015        PMID: 26052565     DOI: 10.11152/mu.2013.2066.172.effbm

Source DB:  PubMed          Journal:  Med Ultrason        ISSN: 1844-4172            Impact factor:   1.611


  6 in total

Review 1.  Biological therapies in otology.

Authors:  A Roemer; H Staecker; S Sasse; T Lenarz; A Warnecke
Journal:  HNO       Date:  2017-08       Impact factor: 1.284

2.  [Biological therapies in otology. German version].

Authors:  A Roemer; H Staecker; S Sasse; T Lenarz; A Warnecke
Journal:  HNO       Date:  2017-07       Impact factor: 1.284

Review 3.  Autologous bone marrow stem cell transplantation for patients undergoing coronary artery bypass grafting: a meta-analysis of 22 randomized controlled trials.

Authors:  Juelin Song; Kang He; Jianglong Hou
Journal:  J Cardiothorac Surg       Date:  2022-06-25       Impact factor: 1.522

4.  Meta-analysis of short- and long-term efficacy of mononuclear cell transplantation in patients with myocardial infarction.

Authors:  Dan Yang; Connor Galen O'Brien; Gentaro Ikeda; Jay H Traverse; Doris A Taylor; Timothy D Henry; Roberto Bolli; Phillip C Yang
Journal:  Am Heart J       Date:  2019-11-11       Impact factor: 4.749

5.  Geniposide from Gardenia jasminoides var. radicans Makino Attenuates Myocardial Injury in Spontaneously Hypertensive Rats via Regulating Apoptotic and Energy Metabolism Signalling Pathway.

Authors:  Ying Hou; Peipei Yuan; Yang Fu; Qi Zhang; Liyuan Gao; Yaxin Wei; Xiaoke Zheng; Weisheng Feng
Journal:  Drug Des Devel Ther       Date:  2021-03-03       Impact factor: 4.162

Review 6.  Stem cells therapy in acute myocardial infarction: a new era?

Authors:  R G Carbone; A Monselise; G Bottino; S Negrini; F Puppo
Journal:  Clin Exp Med       Date:  2021-01-23       Impact factor: 3.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.